| Lastest Insider Transactions Of Intra-Cellular Therapies, Inc. ( ITCI ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ITCI | Intra-Cellular Therapies, Inc. | MARCUS JOEL S | Directior | 2021-06-14 | Sell | 18,289 | 42.27 | 773,076 | 2021-06-15 17:02:24 |
| ITCI | Intra-Cellular Therapies, Inc. | MARCUS JOEL S | Directior | 2021-06-14 | Option Exercise | 20,000 | 38.35 | 767,000 | 2021-06-15 17:02:24 |
| ITCI | Intra-Cellular Therapies, Inc. | RIGGS RORY B | Directior | 2021-05-27 | Option Exercise | 13,767 | 0.00 | 0 | 2021-06-04 16:05:50 |
| ITCI | Intra-Cellular Therapies, Inc. | Alafi Christopher D | Directior | 2021-05-21 | Sell | 27,675 | 40.45 | 1,119,490 | 2021-05-25 18:02:17 |
| ITCI | Intra-Cellular Therapies, Inc. | MARCUS JOEL S | Directior | 2021-03-02 | Sell | 15,250 | 34.93 | 532,683 | 2021-03-04 17:43:43 |
| ITCI | Intra-Cellular Therapies, Inc. | MARCUS JOEL S | Directior | 2021-03-02 | Option Exercise | 20,000 | 26.58 | 531,600 | 2021-03-04 17:43:43 |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | 2021-02-18 | Sell | 2,734 | 39.25 | 107,310 | 2021-02-22 20:09:42 |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | 2021-02-18 | Option Exercise | 8,354 | 0.00 | 0 | 2021-02-22 20:09:42 |
| ITCI | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | 2021-02-18 | Sell | 5,184 | 39.22 | 203,308 | 2021-02-22 20:07:41 |
| ITCI | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | 2021-02-18 | Option Exercise | 11,139 | 0.00 | 0 | 2021-02-22 20:07:41 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2021-02-18 | Sell | 10,442 | 39.23 | 409,625 | 2021-02-22 20:05:28 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2021-02-18 | Option Exercise | 10,442 | 0.00 | 0 | 2021-02-22 20:05:28 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2021-02-18 | Sell | 11,139 | 39.24 | 437,133 | 2021-02-22 20:03:35 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2021-02-18 | Option Exercise | 11,139 | 0.00 | 0 | 2021-02-22 20:03:35 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2021-02-18 | Sell | 27,847 | 39.23 | 1,092,436 | 2021-02-22 20:01:22 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2021-02-18 | Option Exercise | 27,847 | 0.00 | 0 | 2021-02-22 20:01:22 |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | 2021-01-08 | Sell | 4,367 | 32.12 | 140,259 | 2021-01-12 19:07:47 |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | 2021-01-08 | Option Exercise | 13,092 | 0.00 | 0 | 2021-01-12 19:07:47 |
| ITCI | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | 2021-01-08 | Sell | 9,684 | 32.02 | 310,082 | 2021-01-12 19:06:28 |
| ITCI | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | 2021-01-08 | Option Exercise | 20,948 | 0.00 | 0 | 2021-01-12 19:06:28 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2021-01-08 | Sell | 19,638 | 32.02 | 628,769 | 2021-01-12 19:05:30 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2021-01-08 | Option Exercise | 19,638 | 0.00 | 0 | 2021-01-12 19:05:30 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2021-01-08 | Sell | 19,638 | 32.03 | 628,978 | 2021-01-12 19:03:51 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2021-01-08 | Option Exercise | 19,638 | 0.00 | 0 | 2021-01-12 19:03:51 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2021-01-08 | Sell | 41,896 | 32.01 | 1,341,260 | 2021-01-12 19:01:47 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2021-01-08 | Option Exercise | 41,896 | 0.00 | 0 | 2021-01-12 19:01:47 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2021-01-03 | Sell | 15,810 | 31.31 | 495,008 | 2021-01-05 18:13:47 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2021-01-03 | Option Exercise | 16,160 | 0.00 | 0 | 2021-01-05 18:13:47 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2021-01-03 | Sell | 16,160 | 31.30 | 505,834 | 2021-01-05 18:11:47 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2021-01-03 | Option Exercise | 16,160 | 0.00 | 0 | 2021-01-05 18:11:47 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2021-01-03 | Sell | 48,341 | 31.30 | 1,513,271 | 2021-01-05 18:09:03 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2021-01-03 | Option Exercise | 34,341 | 0.00 | 0 | 2021-01-05 18:09:03 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2020-12-18 | Option Exercise | 34,000 | 2.74 | 93,160 | 2020-12-21 16:03:26 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2020-11-17 | Sell | 79,425 | 27.62 | 2,193,446 | 2020-11-19 20:05:49 |
| ITCI | Intra-Cellular Therapies, Inc. | Halstead Michael | EVP and General Counsel | 2020-11-17 | Option Exercise | 75,000 | 13.86 | 1,039,500 | 2020-11-19 20:05:49 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2020-11-11 | Sell | 28,034 | 25.41 | 712,344 | 2020-11-13 17:51:14 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2020-11-11 | Option Exercise | 20,000 | 3.05 | 61,000 | 2020-11-13 17:51:14 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2020-11-10 | Sell | 50,000 | 26.34 | 1,317,101 | 2020-11-12 17:51:19 |
| ITCI | Intra-Cellular Therapies, Inc. | Mates Sharon | Chairman, President & CEO | 2020-11-04 | Sell | 50,000 | 25.00 | 1,250,000 | 2020-11-06 18:00:30 |
| ITCI | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | 2020-10-15 | Sell | 6,792 | 26.80 | 182,026 | 2020-10-16 16:04:36 |
| ITCI | Intra-Cellular Therapies, Inc. | Neumann Mark | EVP, Chief Commercial Officer | 2020-10-15 | Option Exercise | 13,448 | 0.00 | 0 | 2020-10-16 16:04:36 |
| ITCI | Intra-Cellular Therapies, Inc. | Alafi Christopher D | Directior | 2020-09-14 | Buy | 49,500 | 29.60 | 1,465,200 | 2020-09-14 17:03:56 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2020-09-09 | Sell | 41,983 | 31.14 | 1,307,351 | 2020-09-11 19:08:40 |
| ITCI | Intra-Cellular Therapies, Inc. | Hineline Lawrence J. | SVP of Finance CFO | 2020-09-09 | Option Exercise | 26,983 | 12.73 | 343,494 | 2020-09-11 19:08:40 |
| ITCI | Intra-Cellular Therapies, Inc. | Alafi Christopher D | Directior | 2020-09-11 | Buy | 21,000 | 28.08 | 589,680 | 2020-09-11 16:15:29 |
